Silence Therapeutics (United Kingdom)

W14 8TH (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£8,126,907

Nov 22 - Oct 25

TransNAT: Transforming delivery, safety and efficacy of nucleic acid therapeutics: from intracellular uptake to targeting brain and muscle.

SPF award to University of Oxford and Matthew Wood

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}